Scientists Reveal Hidden ‘Fat-Burning’ Organ! ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎



<[link removed]>

September 03


 



Avoid These 3 Liver Killers

Find Out More →
<[link removed]>

 






Have you ever wondered why some people can eat anything they want and not
gain weight?

Because I can promise you, they're not following the "low carb" fad diets
you've been told to try.

So… what is it?

A recent study
<[link removed]>
called "Newly discovered endocrine functions of the liver" revealed that your
liver is theprimary metabolic fat-burning organ in your body.

Many people who are overweight are not fat because of genetics. It's more
likely because their liver has been worn out from years of abuse.

And when your liver becomes clogged, it not only stops burning fat, it stops
removing toxins from your body as well…

At this point, you might experience headaches, brain fog, dark puffy circles
under the eyes, itchy skin, or even irritations like rosacea.

When your liver gets really clogged, it even stops performing it's most
critical functions:Removing cholesterol, fat and sugar from the bloodstream.

These 3 Foods Kill Your Liver (Avoid #1 At All Costs)...

According to Dr. Gina Sam, a leading New York City Gastroenterologist,
there's one food that destroys your liver faster than anything else.

It can even cause the liquefaction of liver cells, causing elevated liver
enzymes and other signs of damage.

Can you guess which one it is? Go ahead and take a guess, and you'll get the
answer from Dr. Gina Sam herself on the next page.


>> French Fries
<[link removed]>

>> Sweet Potatoes
<[link removed]>

>> Pizza
<[link removed]>

>> Fried Chicken
<[link removed]>

<[link removed]>


This is an advertisement. If you no longer wish to receive promotional
messages from this advertiser, pleaseunsubscribe here
<[link removed]>
. 233 W38th St, Unit 68 New York, New York 10018-9998
 








CONNOR'S HEALTH NOTES

The Panel Named for Function Mostly Measures Injury

Connor Hill · InsightfulWord · September 3, 2026

Nothing here is a reason to start or stop any medication, supplement or
treatment. Those decisions belong with a clinician who knows the case. What
follows concerns what a standard set of blood tests measures, which is a
separate matter and a well-documented one.

The panel is universally called liver function tests, and the name is wrong in
a way that has consequences. Most of what it contains does not measure
function. It measures injury and it measures obstruction, which are different
things with different implications.

The reference sources say so directly. Standard clinical texts describe the
term as imprecise and recommend liver chemistries instead, on the grounds that
the majority of the components reflect hepatocellular injury or impaired bile
flow rather than the organ's capacity to do its work.

The distinction is not academic. A person can have markedly abnormal enzymes
with entirely preserved function, and a person with advanced disease can have
enzymes that have returned toward normal because there is less tissue left to
leak them.

Sorting the panel into its three groups takes a paragraph and changes how
every result in it reads. Two of the analytes indicate that cells have been
damaged and their contents have escaped into the blood. Two indicate that bile
is not flowing as it should. Two — measured by different mechanisms — actually
reflect what the organ is still producing.

The popular account runs on a different model entirely, in which the organ
becomes progressively blocked by accumulated material and must be cleared.
There is no such mechanism. The organ does not fill up, does not store toxins
for later, and has no channel that clogs in the sense the metaphor implies.

What it does have is a specific and common problem: fat accumulating within
its cells, which is now the most frequent cause of abnormal enzymes in the
general population, and which has a name, a staging system and an evidence base.

What follows is how the three groups of the panel divide, why the name
misleads, what an elevated transaminase narrows the possibilities to, why the
organ does not clog, and the sequence a clinician actually follows.

Injury, Cholestasis and Synthesis

The panel divides cleanly into three categories once the categories are named,
and each answers a different question.

The injury markers are the two transaminases. One of them is largely confined
to the cytosol of liver cells and is the more specific of the pair. The other
is present in heart, skeletal muscle, kidney and red blood cells as well, which
is why an isolated elevation of it can come from somewhere other than the liver
entirely — vigorous exercise and muscle injury being the common examples.

These enzymes appear in the blood because cells have been damaged and their
contents have leaked. The magnitude indicates roughly how much leakage is
occurring, and the ratio between the two carries some information about cause.

The cholestasis markers indicate impaired bile flow. Alkaline phosphatase is
concentrated in the epithelium lining the bile ducts and rises when flow is
obstructed, but it also comes from bone, placenta and intestine, so an
elevation alone does not localize. Gamma-glutamyl transferase is the analyte
used to confirm that an elevated alkaline phosphatase is hepatobiliary rather
than skeletal in origin.

The synthetic markers are the two that measure function. Albumin reflects the
organ's protein production, and the prothrombin time expressed as a ratio
reflects its production of clotting factors.

Bilirubin sits somewhat apart, reflecting the handling and excretion of a
breakdown product, and its two fractions distinguish problems before the liver
from problems within or beyond it.


Why the Panel Is Misnamed

The naming problem produces specific misreadings, and each of them is common.


🩺 Clinical Signal

Two of the analytes

Of the components in a standard liver panel, only albumin and the prothrombin
time or international normalized ratio reflect synthetic function. The
transaminases indicate hepatocellular injury; alkaline phosphatase and
gamma-glutamyl transferase indicate impaired bile flow. Standard clinical
references describe the term "liver function tests" as imprecise and recommend
"liver chemistries," and note that even the synthetic markers are not
liver-specific — albumin is affected by nutrition and inflammation, and the
clotting measure by vitamin K status and anticoagulants. Source: Liver Function
Tests, StatPearls, National Library of Medicine.


Support or oppose: should the standard panel be renamed on laboratory reports?

Supporters argue that the name causes patients and non-specialist clinicians
to read an enzyme elevation as failing function, that the correct term is
already recommended in reference texts, and that a report should not embed an
error in its title. Opponents answer that the name is embedded in decades of
records, ordering systems and guidelines, that renaming introduces transition
risk in exactly the clinical settings where errors are dangerous, and that the
remedy for a misunderstood label is education rather than a database migration.
Which is better?Hit reply — one line is enough.

The first misreading is treating a raised enzyme as failing function. It is
the opposite: leakage requires living cells to leak from, and a very high
transaminase indicates active injury to tissue that is still there.

The second is treating a normal panel as excluding disease. Established
cirrhosis frequently presents with normal or near-normal transaminases, because
the inflammatory phase has passed. The findings that indicate advanced disease
are a falling albumin, a rising bilirubin, a lengthening clotting time and a
falling platelet count.

The third is reading the synthetic markers as though they were specific. They
are not. Albumin falls in malnutrition, in inflammation of any cause, in
protein loss through the kidney or gut. The clotting measure lengthens with
vitamin K deficiency and with anticoagulant medication, and distinguishing
those from hepatic causes requires knowing what the person takes.

The fourth is comparing values across laboratories. Reference intervals differ
between assays and populations, and the upper limit of normal for the
transaminases has itself been debated, with proposals to lower it because the
historical reference populations included people with undiagnosed fatty liver.


What an Elevated Transaminase Narrows To

An abnormal result is a starting point with a defined differential, and the
pattern of abnormality does most of the narrowing.

The first distinction is the pattern: predominantly hepatocellular,
predominantly cholestatic, or mixed. Comparing how far each analyte is elevated
above its own upper limit sorts a result into one of the three, and the three
lead to different investigations.

The second is magnitude. Modest elevations — a few times the upper limit —
have a broad differential dominated by common conditions. Very high elevations,
in the thousands, have a short list: acute viral infection, drug or toxin
injury, an interruption of blood supply, and a small number of others.

The third is duration. A single abnormal result is often transient and
resolves on repeat testing, which is why repeating the test is a standard first
step rather than a delay.

The most common cause of a persistent modest elevation in the general
population is fat accumulation within liver cells associated with metabolic
factors — obesity, insulin resistance, elevated triglycerides, raised blood
pressure. This condition has been renamed in recent classifications to reflect
that metabolic association explicitly.

Alcohol is the other large contributor and produces a characteristic pattern
in the ratio between the two transaminases. Medications, including common
non-prescription ones taken above recommended doses, are the third large
category, and a complete list of what a person takes is part of the workup
rather than an afterthought.


The Organ Does Not Clog

The popular model deserves direct treatment, because its intuitive appeal is
what carries the claims built on it.


Context — the findings that are not a diet question

Yellowing of the skin or the whites of the eyes, urine that has turned dark or
stool that has turned pale, swelling of the abdomen or the legs, confusion or
unusual drowsiness, vomiting blood, or black tarry stool — none of these are
questions about which foods to include or avoid. Several indicate advanced or
acute disease in which time to assessment matters, and confusion in someone
with known liver disease is an emergency. The material here concerns the
interpretation of routine blood tests in people who are otherwise well, and it
is not a substitute for evaluation by a clinician.

The organ is a chemical processing tissue, not a filter with a mesh. Blood
arrives through two supplies, passes through sinusoids lined with cells that
take up and transform substances, and leaves. Nothing is strained out and
retained.

Its handling of foreign compounds proceeds in two phases: modification of the
molecule, then attachment of a water-soluble group so that it can be excreted
in bile or urine. The products leave. They are not stockpiled.

Bile ducts can genuinely obstruct — by a stone, a stricture, a tumor, or an
inflammatory process — and that obstruction is what the cholestasis markers
detect. It is a mechanical event with a specific cause, identifiable on
imaging, and it is not what dietary language about clogging describes.

Fat accumulation is real and is the closest the popular model comes to
something true. Triglyceride accumulates within the cells themselves, which is
visible on imaging and quantifiable, and it can progress to inflammation and
scarring in a minority of cases. But it is a metabolic state rather than a
blockage, and what reverses it is weight reduction and management of the
associated metabolic factors, for which there is trial evidence.

The claim that a single food destroys the organ faster than anything else does
not correspond to any recognized mechanism. Injury has identifiable causes,
they are enumerated in reference texts, and the enumeration is not a ranking of
foods.


The Sequence a Clinician Actually Follows

The workup for an abnormal result is standardized enough to describe, and
knowing it makes the process legible.

The first step is usually repetition, since a proportion of abnormalities do
not persist. Alongside it comes a history: alcohol intake, all medications
including non-prescription and herbal products, risk factors for viral
infection, family history, and metabolic factors.

The second step is pattern analysis and a first tier of tests directed by it:
viral serology, metabolic markers, and screening for the small number of
inherited and autoimmune conditions that are treatable and would otherwise be
missed.

The third is imaging, most often ultrasound, which shows fat, biliary
dilatation, focal lesions and features suggesting established scarring.

The fourth, where scarring is the question, is non-invasive assessment of
stiffness or a calculated fibrosis score, which have substantially reduced the
need for biopsy. Biopsy remains available where the non-invasive results are
equivocal or the diagnosis is unclear.

What the sequence is designed to do is separate the common and metabolic from
the uncommon and specific, because the management differs entirely. That
separation cannot be made from a single number, and it cannot be made from a
list of foods.

The composite point is that the panel measures three different things under
one misleading name, that the pattern and duration of abnormality carry most of
the information, and that the organ has no mechanism corresponding to the one
the popular account describes.


The bill, not the debate

Only two components of a standard liver panel measure function; the rest
measure cell injury or obstructed bile flow, which is why the reference texts
recommend calling it liver chemistries. Advanced disease often shows normal
enzymes. There is no clogging mechanism — there is fat accumulation, which is
metabolic and measurable. If a liver result has been quoted at you, was it the
enzymes or the albumin?Connor Hill reads every reply.


Sources checked: StatPearls, National Library of Medicine — Liver Function
Tests <[link removed]> · American Association
for the Study of Liver Diseases — how to approach elevated liver enzymes
<[link removed]>
·Cleveland Clinic — liver function tests, purpose and interpretation
<[link removed]> ·
NHS Specialist Pharmacy Service — assessing liver function and interpreting
liver blood tests
<[link removed]>
·National Institute of Diabetes and Digestive and Kidney Diseases — liver
disease and metabolic dysfunction-associated steatotic liver disease
<[link removed]> · LiverTox,
National Library of Medicine — clinical and research information on
drug-induced liver injury <[link removed]>


Connor Hill · InsightfulWord





You’re receiving this email from Insightful Word (IW), a brand of TerraTrance
Technologies, LLC.

Our mailing address: 200 Broadway Blvd NEAlbuquerque, NM 87102



Have a question or need assistance? Reply directly to this email or contact us
[email protected] <mailto:[email protected]>



The content of this email may not be copied, reproduced, forwarded, shared, or
distributed without the prior written consent of TerraTrance Technologies, LLC.

Privacy Policy <[link removed]>
Terms & Conditions <[link removed]>
Unsubscribe
<[link removed]>



© 2026 Insightful Word (IW). All Rights Reserved.